Drugs / Flucelvax(R)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03845231 | Apr → Dec 2019 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flucelvax(R) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03845231 ↗ |
| Modality | Vaccine | “current licensed quadrivalent inactivated influenza vaccine (IIV)” NCT03845231 ↗ |
| Route | Intramuscular | “administered via the intramuscular (IM) route” NCT03845231 ↗ |